Certolizumab pegol Completed Phase 2 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00329303Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis